Exploring the Impact of Metformin on Mineral Levels in the Body

Metformin is one of the most commonly used drugs for treating diabetes worldwide, having been in use for over 60 years. While we know it effectively lowers blood sugar levels, its mechanism of action is not fully understood. It is believed that this drug has positive side effects on tumors, inflammation, and atherosclerosis. But how does metformin affect mineral levels in the body?

The Importance of Studying Metformin’s Effect on Minerals

Recent research has shown that diabetic patients experience changes in blood mineral levels, such as copper, iron, and zinc. Chemical studies have indicated that metformin has the ability to bind to certain minerals like copper, which might explain some of its beneficial effects. For this reason, a research team led by Dr. Wataru Ogawa at Kobe University decided to investigate the effect of metformin on mineral levels in the human body.

Dr. Ogawa and his team conducted a study involving about 200 diabetic patients at Kobe University Hospital, dividing them into two groups: one taking metformin and the other not. They analyzed the different mineral levels in their blood serum.

Study Results: Notable Changes in Mineral Levels

The results of this study were published in the journal BMJ Open Diabetes Research & Care, providing clinical evidence for the first time of changes in blood mineral levels in patients taking metformin. The findings showed that patients on the drug had lower levels of copper and iron and higher levels of zinc.

This discovery is significant because changes in copper, iron, and zinc levels are associated with improved glucose tolerance and prevention of complications. Therefore, these changes might be part of metformin’s mechanism of action in the body.

New Innovations: The Drug Imeglimin

Recently, a new diabetes drug called Imeglimin, a derivative of metformin, was approved in Japan. However, it does not have the same ability to bind to minerals. It is believed to have a different mechanism of action, and studies are currently underway to compare the effects of the two drugs.

Researchers aim to gain a deeper understanding of how these drugs work, as such studies could lead to the development of new diabetes medications and treatments by appropriately modifying mineral concentrations in the body.

Conclusion

The study conducted by the Kobe University team is an important step toward understanding the complex effects of metformin on the body, particularly concerning blood mineral levels. As research continues, these discoveries could lead to the development of new and more effective treatments for diabetes and its complications. Understanding the causal relationship between drug action and its effects remains a primary goal in future research, potentially contributing to improved public health for diabetic patients worldwide.